EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Drug cross-reactivity between methimazole and propylthiouracil causing recurrent pancreatitis in thyroid storm

Yuriko Yamazaki iD, Junichiro Adachi, Yurika Ishihara, Yuto Moriwaki, Wataru Muraoka, Sho Miyashita, Yuki Okuno, Takashi Omura, Yoshihiko Izumida

Endocrinology, Diabetes & Metabolism Case Reports · 01.04.2026 · 2026 (2)

DOI: 10.1530/edm-25-0135 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Endocrinology, Diabetes & Metabolism Case Reports, online erschienen am 03.04.2026. Verfasst von Yuriko Yamazaki und 8 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-induced pancreatitis represents 1.1% of acute pancreatitis cases. To date, eight cases of antithyroid drug (ATD)-induced pancreatitis have been reported, including seven associated with methimazole (MMI) and one with carbimazole; however, no cases related to propylthiouracil (PTU) have been reported in the literature. We report a patient with thyroid storm who developed acute pancreatitis during MMI therapy, with recurrence following PTU substitution, suggesting cross-reactivity between antithyroid agents. The patient demonstrated elevated serum immunoglobulin G4 (IgG4) concentrations. The clinical presentation and imaging findings (onset during corticosteroid therapy and absence of specific computed tomography findings) supported a diagnosis of drug-induced rather than IgG4-related autoimmune pancreatitis. However, IgG4-mediated autoimmune hyperactivity may predispose to immunological cross-reactions between antithyroid drugs. In patients with MMI-induced pancreatitis and elevated IgG4 levels, PTU cross-reactivity should be anticipated. Alternative therapies, including potassium iodide, radioactive iodine ablation, or thyroidectomy, warrant consideration when immunological dysfunction is suspected based on elevated IgG4 concentrations. Learning points

Schlagwörter

Stichwörter der Autor:innen

IgG4drug cross-reactivitydrug-induced pancreatitismethimazolepropylthiouracil

Autor:innen und Institutionen

ORCID-Profile: Yuriko Yamazaki

Zitieren

APA

Yamazaki, Y., Adachi, J., Ishihara, Y., Moriwaki, Y., Muraoka, W., Miyashita, S., Okuno, Y., Omura, T., & Izumida, Y. (2026). Drug cross-reactivity between methimazole and propylthiouracil causing recurrent pancreatitis in thyroid storm. Endocrinology, Diabetes & Metabolism Case Reports, 2026(2). https://doi.org/10.1530/edm-25-0135

Vancouver

Yamazaki Y, Adachi J, Ishihara Y, Moriwaki Y, Muraoka W, Miyashita S, et al. Drug cross-reactivity between methimazole and propylthiouracil causing recurrent pancreatitis in thyroid storm. Endocrinology, Diabetes & Metabolism Case Reports. 2026;2026(2). doi:10.1530/edm-25-0135

BibTeX
@article{Yamazaki2026,
  author = {Yamazaki, Yuriko and Adachi, Junichiro and Ishihara, Yurika and Moriwaki, Yuto and Muraoka, Wataru and Miyashita, Sho and Okuno, Yuki and Omura, Takashi and Izumida, Yoshihiko},
  title = {Drug cross-reactivity between methimazole and propylthiouracil causing recurrent pancreatitis in thyroid storm},
  journal = {Endocrinology, Diabetes & Metabolism Case Reports},
  year = {2026},
  volume = {2026},
  number = {2},
  doi = {10.1530/edm-25-0135}
}
Kostenlos starten →